Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.

Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.5.2 to the history log and removed Revision: v3.5.0. This updates the record's version history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3 from the history.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.4.3 was added to the record history, replacing the previous revision (v3.4.2).SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Document Section, Contacts/Locations, and Study Identification entries (including a 'No Results Posted' status on 2026-02-19) and removed the 2024-05-31 'Results Submitted' events.SummaryDifference1%

- Check69 days agoChange DetectedThe version history shows four new Results Submission Events added and three removed, updating the record with recent results submission activity. This reflects ongoing maintenance of the study record.SummaryDifference0.1%

- Check76 days agoChange DetectedA new Revision: v3.4.2 was added to the history. The previous government funding operating status notice and Revision: v3.4.1 were removed.SummaryDifference0.7%

Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.